Results 181 to 190 of about 34,845 (214)

AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study.

open access: yesJMIR Cancer
Claessens A   +8 more
europepmc   +1 more source

Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Circadian regulation of metabolism is an important factor in metabolic health, yet the role of rhythmic metabolites in Type 2 diabetes development remains poorly understood. This study investigated associations between circulating rhythmic metabolites and incident Type 2 diabetes risk and evaluated causal relationships using two‐sample ...
Divya Joshi   +10 more
wiley   +1 more source

Type 5 diabetes mellitus: redefining pancreatogenic diabetes through molecular, imaging, and AI-driven evidence. [PDF]

open access: yesFront Endocrinol (Lausanne)
Rangraze IR   +13 more
europepmc   +1 more source

Advances in Electrocardiogram‐Based Non‐Invasive Blood Glucose Monitoring Technology

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Blood glucose monitoring is fundamental to diabetes management, yet traditional invasive methods are limited by patient discomfort and infection risks. In recent years, electrocardiogram (ECG), a conventional tool for cardiovascular assessment, has gained attention as a prospective method for non‐invasive blood glucose monitoring.
Qi Zeng   +5 more
wiley   +1 more source

Artificial Intelligence in Type 1 Diabetes Management: A Scoping Review of Randomised Controlled Trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Artificial intelligence is emerging in healthcare systems. In type 1 diabetes, AI‐enabled tools are increasingly used to support nutrition assessment and insulin decision‐making, yet their clinical utility and safety remain unclear. Methods The study aims to identify and map the evidence on the clinical utility of AI‐based diabetes ...
Yucen Wu   +4 more
wiley   +1 more source

Artificial Pancreas: The First 20 Years. [PDF]

open access: yesJ Diabetes Sci Technol
Doyle FJ, Kovatchev BP.
europepmc   +1 more source

Home - About - Disclaimer - Privacy